Zaima Mazorra Herrera
Affiliation: Center of Molecular Immunology
- Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patientsZaima Mazorra Herrera
Clinical Immunology Department at Clinical Direction, Center of Molecular Immunology, Street 216 Corner 15, PO Box 16040, Havana, Cuba
Cancer Immunol Immunother 63:737-47. 2014..We also discuss preliminary findings obtained in a trial of combination of these two vaccines and future challenges with these therapies. ..
- Immunosenescence and gender: a study in healthy CubansBeatriz García Verdecia
Department of Clinical Immunology, Center of Molecular Immunology, P, O, Box 16040, 216 St, Havana, Cuba
Immun Ageing 10:16. 2013..The aim of this study was to determine the effect of ageing on lymphocytes in a population with a high prevalence of CMV infection in all ages, and to compare gender differences related to the immunosenescence markers...
- Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challengeZaima Mazorra
Department of Vaccines, Center of Molecular Immunology, Havana, Cuba
Cancer Immunol Immunother 57:1771-80. 2008..Paradoxically, in spite of the glycolipidic nature of this antigen, these findings demonstrate the direct involvement of the cellular immune response in the anti-tumour protection induced by a ganglioside-based vaccine...